We are international
• health professionals TEXT SIZE   
webcasts    back

KOS 2007:Melphalan-Prednisone-Thalidomide (MP-T) is Also Superior to Melphalan-Prednisone (MP) in Patients 75 Years of Age or Older with Untreated Multiple Myeloma (MM). Preliminary Results of the Randomized, Double-Blind, Placebo Controlled IFM 01-01 Trial
Cyrille Hulin, MD
Itergroupe Francophone du Myélome
Audio of Dr. Hulin's presentation.

 related articles